AC Immune (ACIU) Cash from Discontinued Operations (2015 - 2025)

AC Immune (ACIU) has 11 years of Cash from Discontinued Operations data on file, last reported at 140839838.12 in Q3 2025.

• On a quarterly basis, Cash from Discontinued Operations fell 217.19% year-over-year to 140839838.12 in Q3 2025; TTM through Sep 2025 was 41551880.84, a 146.6% decrease from a year earlier, with the FY2016 full-year figure at 62665810.51, up 36.72% from the prior year.
• Cash from Discontinued Operations for Q3 2025 stood at 140839838.12, down from 22067050.63 in the prior quarter.
• Over the last five years, Cash from Discontinued Operations for ACIU reached as high as 120181829.23 in Q3 2024 and fell as low as 140839838.12 in Q3 2025.
• Historically, Cash from Discontinued Operations has averaged 15596427.99 across 5 years, with a median of 18164612.47 in 2023.
• Across the five-year window, Cash from Discontinued Operations soared 106.46% in 2024 and tumbled 1980.96% in 2025, its largest moves.
• Year by year, Cash from Discontinued Operations stood at 15791282.96 in 2021, then gained by 11.24% to 14016976.47 in 2022, then fell by 29.59% to 18164612.47 in 2023, then surged by 761.63% to 120181829.23 in 2024, then plunged by 217.19% to 140839838.12 in 2025.
• Per Business Quant data, the three most recent Cash from Discontinued Operations figures were 140839838.12 in Q3 2025, 22067050.63 in Q1 2025, and 120181829.23 in Q3 2024.